Sertraline and imipramine for the treatment of dysthymia.
de Jonghe
F
F
D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D019263:Dysthymic Disorder / Q000188:drug therapy*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design / Q000592:standards; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline
D015057:1-Naphthylamine; D000929:Antidepressive Agents, Tricyclic; D007099:Imipramine; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline